Value of carbohydrate antigen 19-9 in predicting response and therapy control in patients with metastatic pancreatic cancer undergoing first line therapy.

Value of carbohydrate antigen 19-9 in predicting response and therapy control in patients with metastatic pancreatic cancer undergoing first line therapy.

Background:Serum carbohydrate antigen 19-9 (CA 19-9) has been shown to be a sensitive and specific serum marker for pancreatic cancer. Little has been published about correlations between baseline CA 19-9 level or changes to CA 19-9 level and median overall survival (mOS). Its impact on monitoring t...

Full description

Bibliographic Details
Main Authors: Uwe ePelzer, Andreas eHilbig, Jens eStieler, Marianne eSinn, Marcus eBahra, Bernd eDörken, Hanno eRiess
Format: Article
Language:English
Published: Frontiers Media S.A. 2013-06-01
Series:Frontiers in Oncology
Subjects:
Pancreatic Neoplasms
prediction
response
CA 19-9
therapy control
Online Access:http://journal.frontiersin.org/Journal/10.3389/fonc.2013.00155/full

Internet

http://journal.frontiersin.org/Journal/10.3389/fonc.2013.00155/full

Similar Items